Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Short-Term Debt issuances (2024 - 2025)

Mangoceuticals (MGRX) has disclosed Short-Term Debt issuances for 2 consecutive years, with $75000.0 as the latest value for Q4 2025.

  • Quarterly Short-Term Debt issuances rose 300.0% to $75000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37500.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $175000.0 for FY2025, 16.67% up from the prior year.
  • Short-Term Debt issuances hit $75000.0 in Q4 2025 for Mangoceuticals, up from -$37500.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $75000.0 in Q4 2025 to a low of -$37500.0 in Q4 2024.